2012.12.03 Weekly Broadcast Email
The
following updates were made to the CCCWFU CCOP Research Base website for the
week of December 3, 2012.
Accrual
Totals:
During the month
of November, 57 patients were accrued to CCCWFU CCOP Research Base trials.
Congratulations to CTSU and the Michigan CCOP for accruing the most
patients. See the Research Base website spotlight section for
further information.
Adverse
Events:
There
were 4 adverse event received during the month of November.
97509
AE 20
999211
AE 3-5
They
have been attached to this email and summarized on the AE page of the website.
99211(A Feasibility of
Delivering a Quitline Based Smoking Cessation Intervention in Cancer Patients
Receiving Outpatient Treatment)
The
WFU 2012 Continuing Review documents have been added to the website.
99211(A Feasibility of
Delivering a Quitline Based Smoking Cessation Intervention in Cancer Patients
Receiving Outpatient Treatment)AND
99311 (Randomized Placebo-Controlled Pilot
Study of Memantine for Smoking Cessation among Cancer Survivors)
The number of
NicAlert kits available for these studies is the same as the accrual
target. There are sites with a surplus of kits but no patients registered
and many other sites are in need of kits. We are requesting that
sites keep one kit and return the remaining kits to the Research Base at our
expense. Since a kit is not needed at baseline, we will send you an
additional kit if a patient is registered at your site.
You can return kits to the CCCWFU CCOP
Research Base Protocol Information Office. (2000 W. 1st Street
Suite 401, Winston-Salem, NC 27104). Thank
you to the many sites who have already sent in their kits.